-
Alexion Spikes As Company Hires Goldman Sachs (ALXN)
Tuesday, July 30, 2013 - 2:52pm | 194Read More...Shares of Alexion (NASDAQ: ALXN) spiked higher when Bloomberg reported that the pharmaceutical company will be working with Goldman Sachs (NYSE: GS) on a potential takeover by Roche (OTC: RHHBY). Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million...
-
Morgan Stanley Comments on Higher Bid for Illumina
Thursday, March 29, 2012 - 9:57am | 119Read More...Morgan Stanley has published a research report on Illumina (NASDAQ: ILMN) commenting on the company's increased offer from Roche of $51/share. In the report, Morgan Stanley writes, "With this new bid, Roche (covered by Peter Verdult) hopes to open negotiations with the company and have its slate...
-
Oppenheimer Maintains Perform on Illumina After Increased Roche Bid
Thursday, March 29, 2012 - 9:51am | 163Read More...Oppenheimer has published a research report on Illumina (NASDAQ: ILMN) after the company received an additional 15% of value from its Roche offer. In the report, Oppenheimer writes, "Roche has upped its hostile bid to acquire ILMN by raising its offer ~15% to $51/share to be tendered by April 20th...
-
Auriga Maintains Buy on Illumina After Roche Acquisition Proposal
Wednesday, January 25, 2012 - 9:25am | 146Read More...Auriga has published a research report on Illumina (NASDAQ: ILMN) commenting on Roche's tender offer to acquire the company for $44.50/share. In the report, Auriga writes, "Roche noted its offer is a 64% premium over ILMN's stock price on December 21, 2011 – one day prior to rumors about a...
-
Goldman Sachs Moves Illumina to Not Rated
Wednesday, January 25, 2012 - 8:37am | 22Read More...Goldman Sachs has moved Illumina (NASDAQ: ILMN) to Not Rated pending the Roche acquisition.
-
Piper Jaffray Maintains Neutral on Illumina After Roche's Tender Offer
Wednesday, January 25, 2012 - 8:13am | 141Read More...Piper Jaffray has published a research report on Illumina (NASDAQ: ILMN) after Roche announced a $44.50/share tender offer to acquire the company last night. In the report, Piper Jaffray writes, "Roche announced a tender offer to acquire Illumina for $44.50 or ~$5.7B on a fully diluted basis,...
-
Oppenheimer Maintains Perform on Illumina's Proposed Acquisition by Roche
Wednesday, January 25, 2012 - 7:24am | 150Read More...Oppenheimer has published a research report on Illumina (NASDAQ: ILMN) after the announcement late last night that Roche offered to acquire the company for $44.50/share. In the report, Oppenheimer writes, "Late last night, Roche announced an offer to acquire all outstanding shares of ILMN stock...
-
Current Top Percentage Gainers And Losers (XNPT, DGW, IMGN, TPCG, DBLE, GSK, QXM, QTWW, RT, SUPG, NLST)
Thursday, April 7, 2011 - 12:29pm | 291Read More...Best 1) XenoPort (NASDAQ: XNPT): An FDA approval for one of its drugs, along with partner GlaxoSmithKline (NYSE: GSK), has shares vaulting. Posting a huge gain of 63.32% to $10.41. 2) Duoyuan Global Water (NYSE: DGW): Stock has exploded 25% to $4.04 since starting the day in negative territory. The...
-
Pre-Market Top Percentage Gainers and Losers (XNPT, GSK, ZAGG, LOGI, BBBY, PRXL, BLUD, INHX, PWER, INTC, TZOO, KERX)
Thursday, April 7, 2011 - 9:11am | 313Read More...Best 1) XenoPort (NASDAQ: XNPT): Posting a huge pre-market gain of 68.61% to $10.77. An FDA approval for its drug, along with partner GlaxoSmithKline (NYSE: GSK), has shares skyrocketing. 2) ZAGG (NASDAQ: ZAGG): Trading up 13% to $9.28. Investors are responding well to an agreement with Logitech...
